Status:
COMPLETED
A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborating Sponsors:
The First Affiliated Hospital of Zhengzhou University
Conditions:
Thyroid Papillary Carcinoma
Eligibility:
All Genders
Brief Summary
To establish and validate a suitable and practical nomogram for primary hospitals to predict the risk of central lymph node metastasis (CLNM) among thyroid papillary carcinoma (PTC) patients based on ...
Detailed Description
1000 Patients who underwent total thyroidectomy or lobectomy and were diagnosed as PTC by pathological examination between June 2014 and September 2019 in Sun Yat-sen Memorial Hospital (Guangzhou, Sou...
Eligibility Criteria
Inclusion
- underwent TC operation for the first time
- confirmed as PTC by postoperative pathological examination
- underwent ipsilateral or bilateral CLND
Exclusion
- complicated with other subtypes of TC or thyroid metastatic cancer
- received preoperative interventional therapy (such as radiofrequency and microwave therapy) or head and neck radiotherapy
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05191927
Start Date
January 1 2020
End Date
August 1 2021
Last Update
January 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China